Compile Data Set for Download or QSAR
Report error Found 114 Enz. Inhib. hit(s) with Target = 'Stimulator of interferon genes protein [140-379]'
TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562465(US11401295, Compound 4C)
Affinity DataIC50: 1.44E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562473(US11401295, Compound 6B)
Affinity DataIC50: 1.76E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562457(US11401295, Compound 2B)
Affinity DataIC50: 2.00E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562463(US11401295, Compound 4B)
Affinity DataIC50: 2.26E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562472(US11401295, Compound 6A)
Affinity DataIC50: 2.39E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562477(US11401295, Compound 6C)
Affinity DataIC50: 2.40E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562479(US11401295, Compound 6D)
Affinity DataIC50: 2.53E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562461(US11401295, Compound 3D)
Affinity DataIC50: 2.70E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562462(US11401295, Compound 4A)
Affinity DataIC50: 2.76E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562468(US11401295, Compound 5A)
Affinity DataIC50: 2.81E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562467(US11401295, Compound 4D)
Affinity DataIC50: 2.86E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562460(US11401295, Compound 3C)
Affinity DataIC50: 2.93E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562440(US11401295, Compound 1B)
Affinity DataIC50: 3.21E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562456(US11401295, Compound 2A)
Affinity DataIC50: 3.58E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562453(US11401295, Compound 1C)
Affinity DataIC50: 3.73E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562459(US11401295, Compound 3B)
Affinity DataIC50: 4.35E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562470(US11401295, Compound 5C)
Affinity DataIC50: 4.97E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562471(US11401295, Compound 5D)
Affinity DataIC50: 5.14E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562469(US11401295, Compound 5B)
Affinity DataIC50: 5.47E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562455(US11401295, Compound 1D)
Affinity DataIC50: 5.61E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562458(US11401295, Compound 3A)
Affinity DataIC50: 5.91E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM50506263(CHEMBL4465054 | US11401295, Compound 2',3'-cGAMP)
Affinity DataIC50: 6.66E+3nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Mountain lion)
Shanghai Jemincare Pharmaceuticals

US Patent
LigandPNGBDBM562437(US11401295, Compound 1A)
Affinity DataIC50: 1.40E+4nMAssay Description:Fluorescence polarization assay (FP assay) was used to detect the affinity of compounds for human STING proteins. There were a certain amount of fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564885(US11414387, Compound 40)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564886(US11414387, Compound 41)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564890(US11414387, Compound 47)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564901(US11414387, Compound 59)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564902(US11414387, Compound 60)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564903(US11414387, Compound 61)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564907(US11414387, Compound 65)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564909(US11414387, Compound 68)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564911(US11414387, Compound 72)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564920(US11414387, Compound 81)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564929(US11414387, Compound 91)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564937(US11414387, Compound 107)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564938(US11414387, Compound 111)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564939(US11414387, Compound 112)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564940(US11414387, Compound 114)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564941(US11414387, Compound 115)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564942(US11414387, Compound 116)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564943(US11414387, Compound 117)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564944(US11414387, Compound 118)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564945(US11414387, Compound 119)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564947(US11414387, Compound 122)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564948(US11414387, Compound 123)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564949(US11414387, Compound 125)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564953(US11414387, Compound 229)
Affinity DataIC50: 1.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564859(US11414387, Compound 13 | US11414387, Compound 97)
Affinity DataIC50: 3.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564869(US11414387, Compound 23)
Affinity DataIC50: 3.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

TargetStimulator of interferon genes protein [140-379](Human)
Stingthera

US Patent
LigandPNGBDBM564875(US11414387, Compound 29 | US11414387, Compound 85)
Affinity DataIC50: 3.00E+5nMAssay Description:Briefly, the recombinant C-terminal ligand binding domain of the human STING protein (140-379) or mouse STING protein (139-328) [0.5 μM] was inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 114 total ) | Next | Last >>
Jump to: